Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF397 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |
mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | MBD1 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
mRNA | ATL1 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
mRNA | ZNF461 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | CAMK2N2 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | DDX25 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | ZNF84 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |